Movies of dopamine transporter occupancy with ultra-high resolution focusing pinhole SPECT

Molecular Psychiatry

Volumn 12, Issue 11, 2007, Pages 984-987

  Vastenhouw, B ^a,b   Van Der Have, F ^a,b   Van Der Linden, A J A ^b   Von Oerthel, L ^c   Booij, J ^c   Burbach, J P H ^b   Smidt, M P ^b   Beekman, F J ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

DAT; Drugs of abuse; In vivo imaging; Mouse; Parkinson; SPECT

Indexed keywords

DOPAMINE TRANSPORTER; N OMEGA FLUOROPROPYL 2BETA CARBOMETHOXY 3BETA (4 IODOPHENYL)NORTROPANE I 123; NEUROTRANSMITTER; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; BRAIN FUNCTION; BRAIN REGION; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; MALE; MESENCEPHALON; MOUSE; NEUROBIOLOGY; NEUROPATHOLOGY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; AUTORADIOGRAPHY; BRAIN; COCAINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; IODINE RADIOISOTOPES; MALE; MICE; MICE, INBRED C57BL; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 35548994085     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/sj.mp.4002028     Document Type: Review

References (21)

1. Booij J, Tissingh G, Winogrodzka A, van Royen EA. Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with Parkinsonism. Eur J Nucl Med 1999; 26: 171-182.
2. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 1987; 237: 1219-1223.
3. Volkow ND, Wang GJ, Fischman MW, Foltin RW, Fowler JS, Abumrad NN et al. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 1997; 386: 827-830.
4. Runyon SP, Carroll FI. Dopamine transporter ligands: recent developments and therapeutic potential. Curr Top Med Chem 2006; 6: 1825-1843.
5. Lee CS, Samii A, Sossi V, Ruth TJ, Schulzer M, Holden JE et al. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease. Ann Neurol 2000; 47: 493-503.
6. 123I] Beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease. Neurology 1996; 46: 231-237.
7. Tissingh G, Booij J, Bergmans P, Winogrodzka A, Janssen AG, van Royen EA et al. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta- (4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease. J Nucl Med 1998; 39: 1143-1148.
8. Ponsen MM, Stoffers D, Booij J, van Eck-Smit BL, Wolters ECh, Berendse HW. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 2004; 56: 173-181.
9. Stiasny-Kolster K, Doerr Y, Moller JC, Hoffken H, Behr TM, Oertel WH et al. Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 2005; 128: 126-137.
10. Nikolaus S, Beu M, Wirrwar A, Antke C, Muller HW. In vivo snapshots of the dopaminergic synapse in small animals. Mol Psychiatry 2005; 10: 516-518.
11. Andringa G, Drukarch B, Bol JG, de Bruin K, Sorman K, Habraken JB et al. Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease. Neuroimage 2005; 26: 1150-1158.
12. Inaji M, Yoshizaki T, Okauchi T, Maeda J, Nagai Y, Nariai T et al. In vivo PET measurements with [11C]PE2I to evaluate fetal mesencephalic transplantations to unilateral 6-OHDA-lesioned rats. Cell Transplant 2005; 14: 655-663.
13. Beekman FJ, van der Have F, Vastenhouw B, van der Linden AJ, van Rijk PP, Burbach JP et al. U-SPECT-I: a novel system for submillimeter-resolution tomography with radiolabeled molecules in mice. J Nucl Med 2005; 46: 1194-1200.
14. Beekman F, van der Have F. The pinhole: gateway to ultra-high-resolution three-dimensional radionuclide imaging. Eur J Nucl Med Mol Imaging 2007; 34: 151-161.
15. Lange K, Carson R. EM reconstruction algorithms for emission and transmission tomography. J Comput Assist Tomogr 1984; 8: 306-316.
16. Neumeyer JL, Wang S, Gao Y, Milius RA, Kula NS, Campbell A et al. N-omega-fluoroalkyl analogs of (1R)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)-tropane (beta-CIT): radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transporters. J Med Chem 1994; 37: 1558-1561.
17. Vastenhouw B, Beekman F. Submillimeter total-body murine imaging with U-SPECT-I. J Nucl Med 2007; 48: 487-493.
18. Kindlundh AM, Rahman S, Lindblom J, Nyberg F. Increased dopamine transporter density in the male rat brain following chronic nandrolone decanoate administration. Neurosci Lett 2004; 356: 131-134.
19. 3H]Beta-CIT: a radioligand for dopamine transporters in rat brain tissue. Eur J Pharmacol 1999; 385: 291-294.
20. Rosen GD, Williams AG, Capra JA, Connolly MT, Cruz B, Lu L et al. The Mouse Brain Library. Int Mouse Genome Conference 2000; 14: 166, (##www.mbl.org##).
21. Williams RW. Mapping genes that modulate mouse brain development: a quantitative genetic approach. Results Probl Cell Differ 2000; 30: 21-49.